Document is current
Any future updates will be listed below
-
Authors
Liang, Zhao
Liu, Yang
Li, Ping
Zhao, Aiqi
Zhang, Honghao
Pang, Cuiying
Chen, Shiqi
Xue, Bin
Li, Zhifang
Qian, Wenbin
Liang, Aibin
Han, Weidong
Li, Yuhua
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82300130)
National Natural Science Foundation of China (82400239)
National Natural Science Foundation of China (82341208)
National Natural Science Foundation of China (82270233)
National Science and Technology Major Project (2023ZD0501303)
Basic and Applied Basic Research Foundation of Guangdong Province (2024A1515011659)
- License Information
-
More Information
Article History
Received: 25 April 2025
Revised: 1 July 2025
Accepted: 28 July 2025
First Online: 14 October 2025
Declarations
:
: The design and final reports of this study complied with the Helsinki Declaration and were approved by the Ethical Review Board of Zhujiang Hospital of Southern Medical University, Second Affiliated Hospital of Zhejiang University, Chinese People's Liberation Army General Hospital, Tongji Hospital of Tongji University. Patients were enrolled from registered clinical trials (NCT04337606, ChiCTR-OOC-16007779, NCT02537977). Informed consent of therapy was obtained from all participants involved in the study.
: Not applicable.
: The corresponding author Weidong Han is a member of the Editorial Board of the journal Immunity & Inflammation. However, he was not involved in the peer-review or decision-making process for this manuscript. The authors declare no other competing interests.
